Phaseline

Targets › PDGF

PDGF: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Gastroenterology; next expected readout Jun 2027.

Open in Phaseline: the race on PDGF, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Nova Southeastern Universityrecombinant human platelet derived growth factor (GEM-21)
recombinant human PDGF for bone regeneration
PDGFPhase 1Intrabony Periodontal DefectJun 2027

Conditions

Intrabony Periodontal Defect (1)

Modalities

protein or peptide (1)

Companies

Nova Southeastern University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.